What Pro-Xylane is

The INCI name is hydroxypropyl tetrahydropyrantriol, CAS 439685-79-7, formula C8H16O5, molecular weight around 192 Da. "Pro-Xylane" is a trade name, not an ingredient name — and that is exactly where purchasing and labelling go wrong: the word "Pro-Xylane" will never appear on an ingredient list, only "hydroxypropyl tetrahydropyrantriol". Any supplier dossier, test report or pack copy that treats "Pro-Xylane" as the INCI name is using it incorrectly and must be corrected to the standard name before it reaches your own pages. It derives from xylose, a pentose abundant in beech and other woods, and belongs to the C-glycoside family; it was developed by L'Oréal research and entered its anti-ageing lines, which is where its reputation comes from.

Its physico-chemical profile is friendly, which is why it holds up around the eyes: a white to off-white powder (neat) or a colourless to pale yellow clear liquid (30% solution grade), freely water-soluble, added straight into the water phase at 75–80 °C with heat tolerance markedly better than most antioxidant actives; the working pH window is about 4.5–7.5, and it sits well in the same system as niacinamide and stable peptides. At roughly 192 Da it is a small molecule, and that is the key difference from large humectants such as hyaluronic acid — the latter mostly forms a surface film, while Pro-Xylane's story points at the skin's own synthesis of structural material.

The purchasing basis has to be settled first, because it is where Pro-Xylane projects most often go wrong: most Pro-Xylane on the market is a 30% aqueous solution grade, with a smaller volume of 98% powder grade. That means the same brief reading "add 3%" corresponds to active contents differing by more than threefold between the two grades. Purchasing and formulation documents must therefore carry three fields: grade (30% solution / 98% powder), raw-material dose, and the converted active-substance content, with the final conversion made against the assay on the supplier COA. Writing "3%" with no basis stated is the single most common cause of rework on this ingredient.

Ingredient fact box

How it works, plainly

The story can be split into three layers, from molecule to appearance: building a little more filler in the matrix, holding two layers more tightly together, and reading as plumper with softer lines. State this first: this section covers mechanistic hypotheses and literature at the cosmetic application level — it is not a medical explanation and carries no efficacy promise.

• Layer one: the glycosaminoglycan (GAG) thread. This is the most recognisable part. GAGs are a family of strongly water-binding macromolecules in the skin's extracellular matrix — hyaluronic acid being the best known. As a xylose-derived C-glycoside, Pro-Xylane is thought to take part in GAG generation, whether as a synthetic precursor or a signalling molecule. Published work and in-vitro testing often cite observations in this "GAG synthesis up-regulation" direction — but be honest: the specific multiples circulating in supplier literature are observations made under in-vitro conditions, and models, concentrations and assay methods vary widely, so they cannot be written into copy as a quantified efficacy promise for a finished product.
• Layer two: the dermal-epidermal junction (DEJ). Dermis and epidermis do not meet on a flat plane; they interlock through a wave-like papillary structure in which collagen IV and VII are key structural proteins. That region flattens with age, and this is one of the structural reasons behind a lax look. Pro-Xylane's second story is precisely supporting synthesis of structural material at this junction, which is why its natural language is "firmness and plumpness" rather than "exfoliation and renewal".
• Layer three: what shows up visually. The upper layers appear as a plumper eye area, fine lines that read shallower, a springier feel. Be honest: this is appearance and skin-feel language, not "collagen regeneration" and certainly not "wrinkle removal". You may write "helps reduce the look of fine lines and laxity around the eyes" or "supports a plumper, more hydrated feel"; you must not write "anti-ageing cure", "removes wrinkles", "stimulates collagen regeneration" or "reverses ageing" — those cross the cosmetic claim boundary.
• An honest note on evidence strength. Published work on Pro-Xylane leans towards in-vitro models or facial human studies, and a fair share of it is tied to its original developer's product applications. Independent eye-area-specific research is not abundant. Verify for yourself on PubMed with "hydroxypropyl tetrahydropyrantriol" and "Pro-Xylane skin". Presenting facial or in-vitro findings as eye-area findings is not rigorous, and no single study may be written up as proof of efficacy.
• How it divides work with retinol and peptides. Pro-Xylane should not be sold as a straight retinol substitute; the routes are entirely different. Retinol acts through turnover and receptor signalling with a clear irritation threshold; Pro-Xylane takes the gentle matrix-and-structure path. The more common and more defensible positioning is "the tier outside retinol" or "the partner used on alternate days". Complementary actives include acetyl hexapeptide-8 for the immediate read of expression lines (see our acetyl hexapeptide-8 eye care guide at ingredient.html?s=acetyl-hexapeptide-8), ceramides for barrier tolerance, and ergothioneine for the antioxidant link (see our ergothioneine eye care guide at ingredient.html?s=ergothioneine).

A blunt note for sourcing: if the brief reads "gentle anti-ageing / suitable for sensitive skin", Pro-Xylane is a clear story, tolerance-friendly with a wide compatibility window. If the expectation is visible line reduction within weeks, it will disappoint — its only honest story is gradual, cumulative plumpness and firmness. More importantly: supplier literature often carries specific in-vitro multiples and comparative lines such as "comparable to retinol", and none of that should be copied onto your product page.

Which formats fit Pro-Xylane best?

Use level and formulation notes (verify by bench trial)

Common reference level: on the most common 30% solution grade, Pro-Xylane raw material commonly sits at about 3%–10% (roughly 0.9%–3% as active substance); on the 98% powder grade, the raw-material dose is usually 1%–3%. But periorbital skin is thinner and less tolerant, so actual dosing usually starts at the lower end and is raised only against stability, skin feel and cost structure. One point deserves emphasis: the figures for the two grades must never be quoted interchangeably — purchasing documents must state grade, raw-material dose and converted active content together, with the final conversion made against the assay on the supplier COA. The actual level is set on the bench by format, compatibility, target-market rules and stability data.

• Viscosity is constraint #1. Pro-Xylane is essentially a polyol-type small molecule, and high dosing markedly disturbs the viscosity structure of an emulsion, showing up as thickness that never builds or a system that thins out. With carbomer systems, neutralise the carbomer fully before adding high-dose Pro-Xylane, or the gel structure thins immediately. The conventional route is to raise the wax phase (fatty alcohols) or switch to salt-tolerant polymeric thickeners, running three to four parallel options during sampling.
• Tackiness is constraint #2. Because the structure resembles a sugar, mid to high dosing brings a distinctly sticky feel, which matters especially in an area where a light touch is expected. The usual correction is to bring in isononyl isononanoate, lightweight silicones or their alternatives and pull the finish back towards velvet or powder.
• pH window. Keep it at 4.5–7.5, with most formulas landing at 5.5–6.0. Compatibility with niacinamide and stable peptides is good inside that range; if a combination with low-pH high-dose acids is genuinely needed, separate the format or the usage step and verify with retained samples.
• Processing. Pro-Xylane is readily heat-tolerant and can be added and fully dissolved in the water phase at 75–80 °C, followed by conventional hot-process emulsification (3–5 minutes of homogenisation). For high-dose formulas, use slow stirring during cooling to reduce aeration.
• Cost structure belongs at kick-off. Pro-Xylane is a high unit-price active, and cost tracks the active-substance content rather than the raw-material dose. Model the target cost on the active basis at project kick-off, or you risk the classic outcome of a formula that passes sampling but cannot be produced at the required cost.
• Stability protocol. 40 °C for 3 months, freeze–thaw and cold-storage observation, with hydroxypropyl tetrahydropyrantriol retention (HPLC), pH drift, viscosity change, appearance and odour as release criteria.
• Label and claim review. Before launch a regulatory adviser must confirm the usable boundary of "firming / plumping / line-softening" copy for each market; the ingredient list must use the standard name "hydroxypropyl tetrahydropyrantriol" and must never present the trade name "Pro-Xylane" as an INCI name.

The figures above are common reference levels for eye care formulas; the actual use level is set by the formulation engineer based on dosage form, compatibility and target-market rules. Permitted use conditions, limits and labelling requirements differ by market — complete a compliance review for each destination before shipment. All descriptions here are general cosmetic applications and appearance or skin-feel statements, not medical advice or efficacy guarantees.

Compliance and market notes (verify per target market)

• China: first verify the listing status and historical maximum use level of Hydroxypropyl Tetrahydropyrantriol (hydroxypropyl tetrahydropyrantriol) in the Inventory of Existing Cosmetic Ingredients in China (2021 edition) (per the latest NMPA announcement). The ingredient name on the label and in the filing must be the standard Chinese name Hydroxypropyl Tetrahydropyrantriol; "玻色因" is a trade name that may appear only in marketing copy, never as an ingredient name. On claims, "anti-ageing", "removes wrinkles" and "stimulates collagen regeneration" are not directions an ordinary cosmetic may claim on its own — use appearance and skin-feel wording such as "帮助减少眼周细纹与松弛外观" and "提升饱满与水润感".
• EU (EC) No 1223/2009: declare the ingredient accurately in the CPNP notification, PIF and CPSR and complete the safety assessment; claims must meet the (EU) No 655/2013 common criteria (legal compliance, truthfulness, evidential support, honesty, fairness, informed decision-making). The word "anti-ageing" is treated cautiously in the practice of several EU member states, so prefer appearance wording such as "helps reduce the look of fine lines" and make sure documentation proportionate to the claim exists.
• US MoCRA (2022): facility registration, product listing, safety substantiation, adverse-event reporting and record-keeping apply, with labelling under the FD&C Act and relevant 21 CFR provisions. Cosmetic ingredients and finished products generally do not undergo pre-market approval — never write "FDA approved". A further caution: any copy implying an effect on skin structure or physiological function risks being read as a drug claim, reclassifying the product.
• Claim red lines (all markets): never use medical, physiological or absolute wording such as "anti-ageing cure", "removes wrinkles", "reverses ageing", "stimulates collagen regeneration", "repairs the dermis", "medical-grade" or "comparable to retinol". On the Chinese site use appearance and skin-feel wording such as "帮助减少眼周细纹与松弛外观", "提升饱满感" and "改善干燥带来的粗糙感".
• Recommended action: at kick-off, give your regulatory adviser five items — ingredient (with grade and active-content conversion), use level and basis, dosage form, target country and proposed claim copy — for one upfront review. Also require legal sign-off line by line on any copy containing firming or anti-ageing language, since that pair of words is the easiest route on this site into drug or medical claim territory.

Ingredient pairings

• Pro-Xylane + sodium hyaluronate + glycerin: the most basic and steadiest combination. Pro-Xylane tells the "help skin build its own" story while HA and glycerin handle "hold water now" — one structural, one immediate — which together reads more completely on a hollowness brief around the eyes.
• Pro-Xylane + acetyl hexapeptide-8 (2%–5%): covers both "long-term firmness" and "immediate expression-line read". For the hexapeptide pathway see our acetyl hexapeptide-8 eye care guide (ingredient.html?s=acetyl-hexapeptide-8); both are water-soluble with good processing compatibility.
• Pro-Xylane + ceramides + panthenol: a barrier-first combination for sensitive or low-tolerance lines, with ceramides handling tolerance and panthenol supplying immediate soothing and hydration.
• Pro-Xylane + ergothioneine + vitamin E: a two-line antioxidant plus matrix structure that suits a "daytime protective anti-ageing" positioning; for the ergothioneine pathway see our ergothioneine eye care guide (ingredient.html?s=ergothioneine).
• Pro-Xylane + retinol (used apart): coexistence in one system is not recommended, but an alternating scheme or a two-SKU pairing — retinol at night, Pro-Xylane at other times — works well, balancing the efficacy story with tolerance management.
• Use with care: adding high-dose Pro-Xylane to a carbomer system before the carbomer is fully neutralised thins the gel immediately, so change the order of addition or the thickener; low-pH high-dose acid systems are better separated by format or usage step; and avoid stacking several polyol-type actives at high dose, since cumulative viscosity loss, tackiness and cost all become unmanageable — cap the formula at two to three headline actives.

Formulation pairing cards

FAQ

Image briefs